[HTML][HTML] The association of homocysteine, folate, vitamin B12, and vitamin B6 with fracture incidence in older adults: a systematic review and meta-analysis
T He, X Jin, YS Koh, Q Zhang, C Zhang… - Annals of Translational …, 2021 - ncbi.nlm.nih.gov
Background Diverse conclusions have been drawn regarding the association of
homocysteine (HCY) deficiency and supplements of B vitamins with fracture incidence in …
homocysteine (HCY) deficiency and supplements of B vitamins with fracture incidence in …
Tetracycline-grafted mPEG-PLGA micelles for bone-targeting and osteoporotic improvement
Y Que, Y Yang, H Zafar, D Wang - Frontiers in Pharmacology, 2022 - frontiersin.org
Aim: We aimed to create a nano drug delivery system with tetracycline (TC)-grafted methoxy
poly-(ethylene-glycol)‒poly-(D, L-lactic-co-glycolic acid)(mPEG‒PLGA) micelles (TC …
poly-(ethylene-glycol)‒poly-(D, L-lactic-co-glycolic acid)(mPEG‒PLGA) micelles (TC …
Making sense of the highly variable effects of alcohol on bone
RT Turner, LH Sattgast, VA Jimenez, KA Grant… - Clinical Reviews in …, 2021 - Springer
Alcohol consumption is often reported to influence bone health in a dose-dependent manner
where moderate alcohol intake is deemed beneficial and heavy drinking detrimental …
where moderate alcohol intake is deemed beneficial and heavy drinking detrimental …
The synergistic effect of plasminogen activator inhibitor-1 (PAI-1) polymorphisms and metabolic syndrome on coronary artery disease in the Korean population
HS Park, JH Sung, CS Ryu, JY Lee, EJ Ko… - Journal of Personalized …, 2020 - mdpi.com
The most common type of cardiovascular disease is coronary artery disease (CAD), in which
a plaque builds up inside the coronary arteries that can lead to a complete blockage of …
a plaque builds up inside the coronary arteries that can lead to a complete blockage of …
Association between PAI-1 Polymorphisms and Ischemic Stroke in a South Korean Case-Control Cohort
GH Choi, SH Cho, HJ An, HS Park, JY Lee… - International Journal of …, 2023 - mdpi.com
Stroke is the second leading cause of death in the world. Approximately 80% of strokes are
ischemic in origin. Many risk factors have been linked to stroke, including an increased level …
ischemic in origin. Many risk factors have been linked to stroke, including an increased level …
[HTML][HTML] Urolithin A attenuates osteoclast differentiation and compensates for ovariectomy-induced bone loss in mice by inhibiting PI3K/AKT/mTOR signaling pathway
W Zhou, W Zhou, Z Zhou, Y Bi, Z Zhou, S Chen, Z Lin… - Phytomedicine Plus, 2024 - Elsevier
Backgrounds and purposes Osteoporosis (OP) is a debilitating illness distinguished by a
reduction in bone density and microstructure, which leads to fragility, fracture risk, and …
reduction in bone density and microstructure, which leads to fragility, fracture risk, and …
Association of IL-6 and TGF-β Gene Polymorphisms with the Risk of Thoracolumbar Osteoporotic Vertebral Compression Fractures
Y Xiong, Y He, Y Peng, Y Geng - … and Personalized Medicine, 2022 - Taylor & Francis
Purpose Osteoporotic vertebral compression fracture (OVCF) is a common disease in the
elderly, and genetic factors play a key role in its occurrence. The present study was …
elderly, and genetic factors play a key role in its occurrence. The present study was …
3′-UTR Polymorphisms of MTHFR and TS Associated with Osteoporotic Vertebral Compression Fracture Susceptibility in Postmenopausal Women
Postmenopausal osteoporosis is one of the most prominent diseases in postmenopausal
women and it is increasing in prevalence with the aging population. Furthermore …
women and it is increasing in prevalence with the aging population. Furthermore …
A small‐molecule PAI‐1 inhibitor prevents bone loss by stimulating bone formation in a murine estrogen deficiency‐induced osteoporosis model
G Jin, A Aobulikasimu, J Piao, Z Aibibula… - FEBS Open …, 2018 - Wiley Online Library
Osteoporosis is a progressive bone disease caused by an imbalance between bone
resorption and formation. Recently, plasminogen activator inhibitor‐1 (PAI‐1) was shown to …
resorption and formation. Recently, plasminogen activator inhibitor‐1 (PAI‐1) was shown to …
Clinical efficacy of PVP and PKP in the treatment of OVCFs after bilateral resection of ovarian cancer
S Wang, H Wang, L Niu - Oncology Letters, 2018 - spandidos-publications.com
The clinical efficacy of percutaneous vertebroplasty (PVP) and percutaneous kyphoplasty
(PKP) in the treatment of osteoporotic vertebral compression fractures after bilateral …
(PKP) in the treatment of osteoporotic vertebral compression fractures after bilateral …